1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAdult Size Changing Tables Grant is sponsored by Tennessee Department of Disability and Aging Services. Offers funding for the installation of adult-sized changing tables in public facilities to support individuals with disabilities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Private and municipal entities within Tennessee; facilities open to the public. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000 per table. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Adult Size Changing Tables Grant is funded by Tennessee Department of Disability and Aging Services. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Tennessee. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Tennessee's $206.9M RHTP allocation begins distribution with a 30-day virtual maternal/child mental health consultation grant. The state plans a new opportunity every Friday — the cadence and structure here are the blueprint for how the $50B nationwide program rolls out.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article